An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. That’s according to a new study from Washington University School of ...

Now, researchers from Mass General Brigham have developed an innovative at-home smell test that could harness this knowledge to detect Alzheimer’s disease years before traditional symptoms emerge.

Mar. 31, 2025 — A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to ...

A recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab ...

Alzheimer's is currently incurable once symptoms begin, but scientists are hoping it's possible to stop its progression with early enough treatment. © sfam_photo via ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of ...

The battle against Alzheimer’s disease continues to challenge medical researchers worldwide, but a simple fermented milk drink might offer unexpected benefits for those affected by this ...

Alzheimer’s is a devastating disease that afflicts roughly 6.7 million Americans, but scientists may have just found a way to reverse its effects by using a common herb found in many products ...

Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious ...

He died of Alzheimer’s in 2019, at the age of 66. “That’s old for our family,” Reiswig said. For years, Reiswig resisted finding out whether he carried the mutation, but he did get tested ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study.